2016 New Frontiers in the German Cancer Diagnostics Market is VPGMarketResearchs new study of the major business opportunities emerging in the German cancer diagnostics market during the nextfive years. The report examines trends in the German cancer diagnostics markets, reviews current and emerging assays; analyzes potential applications of new diagnostic technologies; forecasts sales of major tumor markers by market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers.
The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion worldwide.
Germany Market Overview
- Five-year test volume and sales projections.
- Comprehensive market segmentation analysis, including review
of the market dynamics, structure, size, growth and major suppliers.
- Estimated universe of laboratories performing cancer diagnostic testing.
- Cancer statistics, etiology and recent developments.
Business Opportunities and Strategic Recommendations
- Specific new product development opportunities with potentially
significant market appeal during the next five years.
- Design criteria for new products.
- Alternative market penetration strategies.
- Potential market entry barriers and risks.
Over 200 Current and Emerging Cancer Diagnostic Test
- Biochemical Markers
- Growth Factors
- Colony Stimulating Factors
- Immunohistochemical Stains, and others.
- ACTH, AFP, Beta-2 Microglobulin, CA 15-3/27.29, CA 19-9, CA 125, Calcitonin, Cathepsin, CEA,
Chromogranin, Colon-Specific Antigen, Cytokeratins, Estrogen Receptor, Ferritin, Gastrin, HCG,
Insulin, Interferons, Interleukins, Lymphocyte Subtyping, Neuron-Specific Enolase, Nucleolar,
Occult Blood, Oncogenes, Pancreatic Oncofetal Antigen, Pap Smear, Parathyroid Hormone,
Progesterone Receptor, Prostatic Acid Phosphatase, Prostatic Specific Antigen, S-100 Protein,
Serotonin, Sialic Acid, Squamous Cell Carcinoma Ag, TDT, Thymidine Kinase, Thyroglobulin,
Tissue Polypeptide Antigen, and others.
Supplier Shares, Sales and Volume Forecasts
- Sales and market shares of major cancer diagnostic product
suppliers by individual test.
- Five-year test volume and sales forecasts
for major tumor markers by market segment, including:
- Commercial/Private Laboratories
- Physician Offices
- Analysis of major molecular diagnostic and immunodiagnostic analyzers
used for cancer testing, including their operating characteristics,
features and selling prices.
- Assessment of latest molecular diagnostic methods,
biochips/microarrays, biosensors, monoclonal antibodies, immunoassays,
chromosome analysis, IT, artificial intelligence, flow cytometry, and other technologies
and their potential applications for cancer diagnostic testing.
- Review of competing/complementing technologies, including
CT, MRI, NMR, PET and photonics spectroscopy.
- Extensive listings of companies, universities
and research centers developing new cancer diagnostic tests
and detection technologies.
- Strategic assessments ofmajor suppliers
and start-up firms developing innovative
technologies and products, including their sales,
product portfolios, marketing tactics, collaborative
arrangements, and new products in R&D.
- The companies analyzed in the report include
- Agilent Technologies
- Applied Gene Technologies
- Arca Biopharma
- Beckman Coulter/Danaher
- Becton Dickinson
- Biomedical Diagnostics
- Correlogic Systems/Vermillion
- Decode Genetics
- Eiken Chemical
Contains 585 pages and 95 tables
SIMILAR MARKET STUDIES
Spain In Vitro Diagnostics (IVD) Market Outlook to 2021 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture Summary GlobalDatas new report, Spain In Vitro Diagnostics (IVD) Market Outlook to 2021 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and ...
October 2015 | $9995 | View Details >>
This comprehensive report contains 563 pages and 103 tables. The report explores future trends in the UK market; provides estimates of the specimen, test and sales volumes, as well as major suppliersâ?? sales and market shares; compares features of leading analyzers; profiles key competitors; and identifies specific product and ...
August 2013 | $3950 | View Details >>
Summary ICRWorld’s Synthetic Fibers market research report provides the newest industry data and industry future trends, allowing you to identify the products and end users driving Revenue growth and profitability. The industry report lists the leading competitors and provides the insights strategic industry Analysis of the key factors influencing the market. The ...
May 2017 | $2960 | View Details >>
This new 175-page report from VPGMarketResearch.com provides analysis of the major home/self testing market segments, including diabetes (strips and meters), pregnancy, ovulation, and occult blood. The report presents trends, dynamics, size, growth, regulatory requirements, technologies, and competitive profiles.RationaleThe growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition ...
October 2015 | $450 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research